ABSENTIA LABS, INC

Capabilities

Absential Labs addresses the most expensive and failure-prone stage of drug development: pre-clinical testing. Pharma spends over $15 billion annually on outdated, slow, and ethically problematic methods, with 95% of drug candidates failing to be effective in humans. Our approach is a more scalable, more predictable alternative that has support from the FDA, NIH, EPA, and other government agencies. In terms of approach, we achieve a whole-organism overview for how drugs and compounds impact humans, thereby providing a quicker, safer decision-making and eliminating the need for animal testing.